vs
BALCHEM CORP（BCPC）与和黄医药（HCM）财务数据对比。点击上方公司名可切换其他公司
和黄医药的季度营收约是BALCHEM CORP的1.0倍（$270.8M vs $270.7M），BALCHEM CORP净利率更高（14.9% vs 0.7%，领先14.2%），BALCHEM CORP同比增速更快（8.1% vs -16.5%），BALCHEM CORP自由现金流更多（$33.8M vs $3.4M）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
和黄医药是一家国际化生物制药企业，专注于肿瘤、免疫类疾病的靶向疗法与免疫疗法的研发、生产及商业化，核心市场覆盖中国及全球多个国家地区，已有多款肿瘤治疗药物上市，后期临床管线储备丰富。
BCPC vs HCM — 直观对比
营收规模更大
HCM
是对方的1.0倍
$270.7M
营收增速更快
BCPC
高出24.6%
-16.5%
净利率更高
BCPC
高出14.2%
0.7%
自由现金流更多
BCPC
多$30.5M
$3.4M
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $270.7M | $270.8M |
| 净利润 | $40.3M | $2.0M |
| 毛利率 | — | 37.7% |
| 营业利润率 | 20.5% | -13.2% |
| 净利率 | 14.9% | 0.7% |
| 营收同比 | 8.1% | -16.5% |
| 净利润同比 | 8.7% | -83.6% |
| 每股收益（稀释后） | $1.25 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCHCM
| Q1 26 | $270.7M | — | ||
| Q4 25 | $263.6M | $270.8M | ||
| Q3 25 | $267.6M | — | ||
| Q2 25 | $255.5M | $277.7M | ||
| Q1 25 | $250.5M | $324.5M | ||
| Q4 24 | $240.0M | — | ||
| Q3 24 | $239.9M | — | ||
| Q2 24 | $234.1M | $305.7M |
净利润BCPCHCM
| Q1 26 | $40.3M | — | ||
| Q4 25 | $39.2M | $2.0M | ||
| Q3 25 | $40.3M | — | ||
| Q2 25 | $38.3M | $455.0M | ||
| Q1 25 | $37.1M | $11.9M | ||
| Q4 24 | $33.6M | — | ||
| Q3 24 | $33.8M | — | ||
| Q2 24 | $32.1M | $25.8M |
毛利率BCPCHCM
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | 37.7% | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | 0.1% | ||
| Q1 25 | 35.2% | 48.0% | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | 41.1% |
营业利润率BCPCHCM
| Q1 26 | 20.5% | — | ||
| Q4 25 | 19.8% | -13.2% | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.1% | -1.3% | ||
| Q1 25 | 20.4% | -5.0% | ||
| Q4 24 | 19.8% | — | ||
| Q3 24 | 20.0% | — | ||
| Q2 24 | 19.6% | -9.0% |
净利率BCPCHCM
| Q1 26 | 14.9% | — | ||
| Q4 25 | 14.9% | 0.7% | ||
| Q3 25 | 15.1% | — | ||
| Q2 25 | 15.0% | 163.8% | ||
| Q1 25 | 14.8% | 3.7% | ||
| Q4 24 | 14.0% | — | ||
| Q3 24 | 14.1% | — | ||
| Q2 24 | 13.7% | 8.4% |
每股收益（稀释后）BCPCHCM
| Q1 26 | $1.25 | — | ||
| Q4 25 | $1.21 | $0.00 | ||
| Q3 25 | $1.24 | — | ||
| Q2 25 | $1.17 | $0.52 | ||
| Q1 25 | $1.13 | $0.01 | ||
| Q4 24 | $1.03 | — | ||
| Q3 24 | $1.03 | — | ||
| Q2 24 | $0.98 | $0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.9M | $1.4B |
| 总债务越低越好 | — | $93.2M |
| 股东权益账面价值 | $1.3B | $1.2B |
| 总资产 | $1.7B | $1.8B |
| 负债/权益比越低杠杆越低 | — | 0.08× |
8季度趋势，按日历期对齐
现金及短期投资BCPCHCM
| Q1 26 | $72.9M | — | ||
| Q4 25 | $74.6M | $1.4B | ||
| Q3 25 | $65.1M | — | ||
| Q2 25 | $65.4M | $1.4B | ||
| Q1 25 | $49.9M | $836.1M | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $73.7M | — | ||
| Q2 24 | $63.7M | $802.5M |
总债务BCPCHCM
| Q1 26 | — | — | ||
| Q4 25 | — | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M |
股东权益BCPCHCM
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | $1.2B | ||
| Q1 25 | $1.2B | $759.9M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.1B | $740.1M |
总资产BCPCHCM
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.7B | $1.8B | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.7B | $1.8B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | $1.3B |
负债/权益比BCPCHCM
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $40.1M | $8.2M |
| 自由现金流经营现金流 - 资本支出 | $33.8M | $3.4M |
| 自由现金流率自由现金流/营收 | 12.5% | 1.2% |
| 资本支出强度资本支出/营收 | 2.3% | 1.8% |
| 现金转化率经营现金流/净利润 | 0.99× | 4.21× |
| 过去12个月自由现金流最近4个季度 | — | $-96.2M |
8季度趋势，按日历期对齐
经营现金流BCPCHCM
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $8.2M | ||
| Q3 25 | $65.6M | — | ||
| Q2 25 | $47.3M | $-72.9M | ||
| Q1 25 | $36.5M | $40.3M | ||
| Q4 24 | $52.3M | — | ||
| Q3 24 | $51.3M | — | ||
| Q2 24 | $45.0M | $-39.8M |
自由现金流BCPCHCM
| Q1 26 | $33.8M | — | ||
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-82.2M | ||
| Q1 25 | — | $32.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-49.9M |
自由现金流率BCPCHCM
| Q1 26 | 12.5% | — | ||
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | 10.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -16.3% |
资本支出强度BCPCHCM
| Q1 26 | 2.3% | — | ||
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.3% |
现金转化率BCPCHCM
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | 4.21× | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | -0.16× | ||
| Q1 25 | 0.98× | 3.38× | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | -1.54× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
